Circassia Pharmaceuticals Plc Director/PDMR Shareholding (2441Q)
June 04 2018 - 10:14AM
UK Regulatory
TIDMCIR
RNS Number : 2441Q
Circassia Pharmaceuticals Plc
04 June 2018
Persons Discharging Managerial Responsibilities / persons
closely associated with them (PDMR) Notification
4 June 2018: Circassia Pharmaceuticals plc (LSE: CIR).
1 - Details of the person discharging managerial
responsibilities/person closely associated
Name Steven Harris
----- --------------
2 - Reason for the notification
Position/status Chief Executive Officer
(PDMR)
-------------------------------- ------------------------
Initial notification/amendment* Initial Notification
-------------------------------- ------------------------
In case of amendment, N/A
please enter the previous
notification reference
number and explain the
error that this notification
needs amending
-------------------------------- ------------------------
3 - Details of the issuer, emission allowance market
participant, auction platform, auctioneer or auction monitor
Full name of entity* Circassia Pharmaceuticals
plc
------------------------ --------------------------
Legal Entity Identifier 2138006YAT138TOGA556
code
------------------------ --------------------------
In accordance with ISO
1744 LEI code
------------------------ --------------------------
4 - Details of the transaction(s)
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; (iv) each place where transactions have been conducted
Date Description of Aggregated Aggregated Total
Financial Transaction Price Volume Aggregated
Price
---------- ----------------------- ----------- ----------- ------------
31-May-18 Grant of options GBP0.0008 425,000 GBP340
under the 2018
Share Option
scheme.
---------- ----------------------- ----------- ----------- ------------
i. Award of options
Description of the financial Circassia Pharmaceuticals
instrument, type of instrument Plc 2018 Performance
Share Plan
-------------------------------- --------------------------------
Identification Code N/A
-------------------------------- --------------------------------
Nature of the transaction Award of options
-------------------------------- --------------------------------
Currency GBP
-------------------------------- --------------------------------
Price(s) and Volume (s) Price Volume Total
----------- -------- -------
GBP0.0008p 425,000 GBP340
----------- -------- -------
-------------------------------- --------------------------------
Aggregated Information Price Volume Total
----------- -------- -------
GBP0.0008p 425,000 GBP340
----------- -------- -------
-------------------------------- --------------------------------
Date of Transaction 31 May 2018
-------------------------------- --------------------------------
Place of Transaction London: XLON
-------------------------------- --------------------------------
For further information, please contact:
Circassia Pharmaceuticals plc
Julien Cotta, Company Secretary +44 (0) 1865 405560
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBUGDLXBGBGIS
(END) Dow Jones Newswires
June 04, 2018 11:14 ET (15:14 GMT)
Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2024 to May 2024
Circassia (LSE:CIR)
Historical Stock Chart
From May 2023 to May 2024
